Pharmaceuticals for the treatment of cancer, MRSA, sepsis, immunological diseases and disorders, and age-related diseases and disorders; drug delivery agents as a featured component of pharmaceuticals for the treatment of cancer, MRSA, sepsis, immunological diseases and disorders, and age-related diseases and disorders; house mark for pharmaceuticals and drug delivery agents; * all of the foregoing excluding radio enhancers for use with radiotherapy *

'age':15,42 'age-rel':14,41 'agent':22,54 'cancer':6,33 'compon':26 'deliveri':21,53 'diseas':10,17,37,44 'disord':12,19,39,46 'drug':20,52 'enhanc':61 'exclud':59 'featur':25 'forego':58 'hous':47 'immunolog':9,36 'mark':48 'mrsa':7,34 'pharmaceut':1,28,50 'radio':60 'radiotherapi':65 'relat':16,43 'sepsi':8,35 'treatment':4,31 'use':63

Medical apparatus and units for dosing, namely, drug delivery devices and systems; medical apparatus for introducing pharmaceutical preparations into the human body; * all of the foregoing excluding radio enhancers for use with radiotherapy *

'apparatus':2,14 'bodi':22 'deliveri':9 'devic':10 'dose':6 'drug':8 'enhanc':29 'exclud':27 'forego':26 'human':21 'introduc':16 'medic':1,13 'name':7 'pharmaceut':17 'prepar':18 'radio':28 'radiotherapi':33 'system':12 'unit':4 'use':31

NANOTICS

Owners

Goods & Services